Skip to main content
padlock icon - secure page this page is secure

Pathophysiology and therapeutics of premature ageing in chronic kidney disease, with a focus on glycative stress

Buy Article:

$59.00 + tax (Refund Policy)

Chronic kidney disease (CKD) is a major concern in public health. The pathology of CKD includes premature ageing in the kidney and vessels, which results in a high risk of cardiovascular events and end‐stage renal disease. Many factors are involved in premature ageing in CKD, including hormonal imbalance, glycative stress, nitrogenous metabolites, and oxidative stress. Of these, the most important role in premature ageing in CKD is played by glycative stress, namely a massive and unfavourable glycation state, since the kidney is responsible for the clearance of advanced glycation endproducts (AGEs). In an animal model, overexpression of glyoxalase I (GLO‐1), a detoxifier of AGEs, has been found to alleviate premature ageing in the kidney and vessels. Both lifestyle changes and drug therapy have shown promise in overcoming premature ageing. Promising drug therapies include a GLO‐1 activator and an absorbent against glycotoxin and nitrogenous metabolites.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: GLO‐1; chronic kidney disease; glycative stress; indoxyl sulphate; phosphorus; premature ageing

Document Type: Research Article

Publication date: December 1, 2017

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more